MAIA Biotechnology (MAIA) EPS (Basic) (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly EPS (Basic) of -$0.14 for Q1 2026, up 13.62% year-over-year from -$0.12 in Q1 2025, and down 24.68% quarter-over-quarter from -$0.11 in Q4 2025.
MAIA Biotechnology (MAIA) EPS (Basic) (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported EPS (Basic) for 6 consecutive years, with -$0.14 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 13.62% year-over-year to -$0.14; the TTM figure through Mar 2026 stood at -$0.54 (up 29.46% YoY), while the FY2025 annual figure was -$0.7, up 51.36% from the prior year.
- EPS (Basic) retreated to -$0.14 in Q1 2026 per MAIA's latest filing, from -$0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.11 in Q4 2025 and bottomed at -$0.5 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.32 across 5 years, with a median of -$0.36 in 2023.
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 67.88% — and 2025, when it sank 134.19%.
- MAIA Biotechnology's EPS (Basic) stood at -$0.45 in 2022, then retreated by 5.57% to -$0.47 in 2023, then jumped by 52.97% to -$0.22 in 2024, then jumped by 49.07% to -$0.11 in 2025, then slipped by 24.68% to -$0.14 in 2026.
- Business Quant data shows MAIA's EPS (Basic) at -$0.14 in Q1 2026, -$0.11 in Q4 2025, and -$0.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13 |
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.22 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.36 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.38 |
| Dec 31, 2022 | -0.45 |
| Sep 30, 2022 | -0.48 |
| Jun 30, 2022 | -0.40 |
| Mar 31, 2022 | -0.50 |
| Dec 31, 2021 | -0.55 |
| Sep 30, 2021 | -1.02 |